Dingdang Health (09886) has announced that on September 2, 2026, the company utilized HK$235,000 to repurchase 267,000 of its own shares. This buyback activity reflects the company's ongoing capital management strategy, signaling confidence in its long-term value as it continues to optimize shareholder returns through market operations.
The repurchase was executed in accordance with the company's share buyback mandate, which was approved by shareholders. By reducing the number of outstanding shares, Dingdang Health aims to enhance earnings per share and maintain a supportive market stance. The transaction was carried out on the open market, with the funds allocated from the company's existing cash reserves, not affecting its operational liquidity or growth plans.
Comments